People with metabolic syndrome who follow intermittent fasting see their body’s insulin levels drop, meaning their body is better at using insulin to manage blood sugar.
Scientific Claim
Intermittent fasting reduces fasting insulin levels by 13.25 mU/L in adults with metabolic syndrome over interventions averaging 3 months, indicating improved insulin sensitivity.
Original Statement
“insulin plasma levels reduced by 13.25 uUI (95% CIs: −16.69; −9.82)”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
definitive
Can make definitive causal claims
Assessment Explanation
The effect is statistically significant and derived from RCTs. The verb 'reduces' is appropriate given the causal design and consistent direction of effect.
Evidence from Studies
Supporting (1)
Unknown Title
This study found that people with metabolic syndrome who tried intermittent fasting had much lower insulin levels—exactly as the claim says—and their bodies became better at using insulin, which is a good sign for their health.